AIM ImmunoTech Inc. (AIM)
AMEX: AIM
· Real-Time Price · USD
2.69
0.00 (0.00%)
At close: Aug 22, 2025, 3:53 PM
2.72
1.12%
After-hours: Aug 22, 2025, 07:12 PM EDT
AIM ImmunoTech Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -2.79M | -3.71M | -5.97M | -3.7M | -1.84M | -5.82M | -12.58M | -7.82M | -4.91M | -3.66M | -4.39M | -6.38M | -4.85M | -3.82M | -5.85M | -3.83M | -5.88M | -3.58M |
Depreciation & Amortization | 55K | 58K | 64K | 63K | 61K | 58K | 58K | 53K | 80K | 47K | 170K | 28K | 29K | 29K | 194K | 176K | 178K | 227K |
Stock-Based Compensation | n/a | 60K | 196K | 330K | 80K | 80K | 61K | 50K | 50K | 82K | 162K | 275K | 275K | 242K | 248K | 314K | 480K | 526K |
Other Working Capital | 411K | 248K | 1.29M | -424K | -1.16M | 642K | -398K | 1.3M | 1.66M | -313K | -2.33M | 811K | 2.41M | -107K | 7K | -29K | 998K | 70K |
Other Non-Cash Items | 425K | 436K | 337K | -188K | 957K | 170K | -1.69M | 427K | 105K | -166K | -52K | 386K | -278K | 908K | 1.57M | 63K | 2.52M | 86K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | 2.3M | -318K | -327K | -255K | 946K | -327K | -232K | -190K | -1.78M | -73K | -288K | -181K |
Change in Working Capital | 783K | 790K | 1.42M | 385K | -2.27M | 766K | 2.08M | 1.93M | 2.84M | 273K | -2.91M | 1.05M | 2.74M | 73K | -136K | -111K | 1.27M | -124K |
Operating Cash Flow | -1.53M | -2.36M | -3.96M | -3.11M | -3.01M | -4.82M | -9.76M | -5.67M | -2.16M | -3.68M | -6.07M | -4.97M | -2.31M | -2.76M | -5.75M | -3.46M | -1.72M | -3.04M |
Capital Expenditures | -227K | -56K | -119K | -158K | -229K | -50K | -198K | -184K | -203K | -29K | -175K | -20K | -43K | -33K | -155K | -87K | -26K | -365K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | 47K | 184K | 6K | 29K | n/a | 300K | -7.72M | n/a | 47K | 79K | 245K | 365K |
Purchase of Investments | n/a | -91K | -203K | n/a | n/a | -158K | -438K | -443K | n/a | -712K | -1.06M | -399K | -542K | -720K | -20.92M | 485K | -945K | -1.15M |
Sales Maturities Of Investments | 981K | 1.04M | 4.03M | 492K | 1.05M | 50K | 375K | 326K | n/a | 598K | 1M | 369K | 8.31M | 407K | 21.44M | -764K | -426K | 2.04M |
Other Investing Acitivies | n/a | n/a | n/a | n/a | -229K | -158K | -224K | -219K | -7K | 36K | 3.51M | -50K | 7.72M | -346K | -47K | -79K | 245K | -365K |
Investing Cash Flow | 754K | 898K | 3.7M | 334K | 826K | -158K | -214K | -336K | -204K | -78K | 3.36M | 250K | 7.72M | -346K | 364K | -366K | -1.15M | 523K |
Debt Repayment | 250K | n/a | -251K | 133K | -133K | 2.5M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -4.76M | -93K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | 1.26M | n/a | 2.05M | n/a | 147K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Financial Cash Flow | 355K | 660K | 1.04M | 137K | 2.44M | 2.83M | 147K | 233K | 5K | 100K | n/a | 25K | 55K | n/a | 125K | 30K | -4.76M | 12.79M |
Net Cash Flow | -422K | -803K | 786K | -2.64M | 259K | -2.14M | -9.82M | -5.77M | -2.36M | -3.66M | -2.71M | -4.69M | 5.46M | -3.1M | -5.26M | -3.79M | -7.63M | 10.27M |
Free Cash Flow | -1.76M | -2.42M | -4.07M | -3.27M | -3.24M | -4.87M | -9.96M | -5.86M | -2.36M | -3.71M | -6.24M | -4.99M | -2.36M | -2.79M | -5.9M | -3.54M | -1.74M | -3.41M |